Thrombotic vascular risk factors in inflammatory bowel disease

Gut

Volumn 38, Issue 5, 1996, Pages 733-737

  Hudson, M ^a   Chitolie, A ^b   Hutton, R A ^b   Smith, M S H ^a   Pounder, R E ^a   Wakefield, A J ^a,b  

^a Nuclear Medicine Department   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

inflammatory bowel disease; thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 7; FIBRINOGEN; LIPOPROTEIN A; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; ENTERITIS; FEMALE; HUMAN; INFLAMMATORY DISEASE; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; THROMBOSIS; ULCERATIVE COLITIS; VASCULAR DISEASE;

EID: 0029949731     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.38.5.733     Document Type: Article

References (38)

1. Wakefield AJ, Sawyerr AM, Dhillon AP, Pittilo RM, Rowles PM, Lewis AAM, et al. Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction. Lancet 1989; i: 1057-62.
2. Wakefield AJ, Sankey EA, Dhillon AP, Sawyerr AM, More L, Sim R, et al. Granulomatous vasculitis in Crohn's disease. Gastroenterology 1991; 100: 1279-87.
3. Dhillon AP, Anthony A, Sim R, Wakefield AJ, Sankey EA, Hudson M, et al. Mucosal capillary thrombi in rectal biopsies. Histopathology 1992; 21: 127-33.
4. Bargen JA, Barker NW. Extensive arterial and venous thrombosis complicating chronic ulcerative colitis. Arch Intern Med 1936; 58: 17-31.
5. Talbot RW, Heppell J, Dozois RR, Beart RW. Vascular complications of inflammatory bowel disease. Mayo Clin Proc 1986; 61: 140-5.
6. Graef V, Baggenstoss AH, Sauer WG, Spittell JA. Venous thrombosis occuring with non-specific ulcerative colitis. Arch Intern Med 1966; 117: 277-82.
7. Hudson M, Hutton RA, Wakefield AJ, Sawyerr AM, Pounder RE. Evidence for activation of coagulation in Crohn's disease. Blood Coagul Fibrinolysis 1993; 3: 773-8.
8. Edwards RL, Levine JB, Green R, Duffy M, Matthews E, Brande W. Activation of blood coagulation in Crohn's disease. Gastroenterology 1987; 92: 329-37.
9. Meade TW, Mellows S, Brozovic M, Miller GJ, Chikrabarti HR, North WRS, et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park heart study. Lancet 1996; ii: 533-7.
10. Miller GJ, Bauer KA, Wilkes HC, Meade TW. Plasma prothrombin fragment F1 + 2 concentration is raised in men with an increased factor VII coagulant activity. Q J Med 1991; 80: 561-8.
11. Armstrong VW, Cremer P, Eberle E, Marke A, Schulze F, Weiland, et al. The association between scrum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Atherosclerosis 1986; 62: 249-57.
12. Stone MC, Thorpe JM. Plasma fibrinogen - a major coronary risk factor. J R Coll Gen Pract 1985; 35: 565-9.
13. Rabkin SW, Sackett DL. Arterial thromboembolism. Epidemiology. In: Colman RW, et al, eds. Haemostasis and thrombosis. Philadelphia: J B Lippincott, 1987: 1273-90.
14. Holdstock G, Savage D, Harman M, Wright R: should patients with inflammatory bowel disease smoke? BMJ 1984; 288: 362.
15. Harvey RF, Bradshaw JM. A simple index of Crohn's disease activity. Lancet 1980; i: 514.
16. Dousan KWE. Appendix II. Techniques. In: Biggs R, Macfarlane RG, eds. Human blood coagulation. Haemostasis and Thrombosis. Oxford: Blackwell Scientific, 1972.
17. Miller GJ, Martin JC, Webster J, Wilkes H, Miller NE, Wilkinson WH, et al. Association between dietary fat intake and plasma factor VII coagulant activity - a predictor of cardiovascular mortality. Atherosclerosis 1986; 60: 269-77.
18. Clauss A. Gerinnungs physiologische Schnell method zur bestimmung des fibrinogens. Acta Haematol 1957; 17: 237-46.
19. Rylatt DB, Blake AS, Cottis LE. An immunoassay for human D-dimer using monoclonal antibodies. Thromb Res 1983; 31: 767-78.
20. Rowbotham BJ, Carroll P, Whitaker AN, Bunce IH. Measurement of cross-linked fibrin derivatives - use in the diagnosis of venous thrombosis. Thromb Haemost 1987; 57: 59-61.
21. More L, Sim R, Hudson M, Dhillon AP, Pounder RE, Wakefield AJ. Immunohistochemical study of tissue factor expression in normal intestine and idiopathic inflammatory bowel disease. J Clin Pathol 1993; 46: 703-8.
22. Nemerson Y, Zur M, Bach R, Gentry R. The mechanism of action of tissue factor. In: Main KG, Taylor FB, eds. The regulation of coagulation. Developments in biochemistry. Vol 8. Amsterdam: Elsevier/North Holland, 1980: 193-202.
23. Hawkey CJ, Stirling Y, Chakrabarti R, Brozovic M, Cox AG, Meade TW. Haemostatic changes following surgery. Thromb Res 1983; 32: 223-7.
24. Lane A, Cruickshank JK, Mitchell J, Henderson A, Humphries S, Green F. Genetic and environmental determinants of factor VII coagulant activity in ethnic groups at differing risk of coronary heart disease. Atherosclerosis 1992; 94: 43-50.
25. Orholm M, Iselius L, Sorensen TIA, Munkholm P, Langholz E, Binder V. Investigation of inheritance of chronic inflammatory bowel disease by complex segregation analysis. BMJ 1993; 306: 20-4.
26. Rhoads GG, Dahlem G, Berg K, Morton NE, Dannenberg AL. Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA 1986; 256: 2540-4.
27. Scanu AM, Fless GM. Lipoprotein (a): Heterogeneity and biological relevance. J Clin Invest 1990; 85: 1709-15.
28. Hajjar KA, Gavish D, Breslow JL, Nachman RL. Lipoprotein (a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature 1989; 339: 303-5.
29. Miles LA, Plow EF. Lp(a): an interloper in the fibrinolytic system. Thromb Haemost 1990; 63: 331-5.
30. Conlan MG, Haire WD, Burnett HA. Prothrombotic abnormalities in inflammatory bowel disease. Dig Dis Sci 1989; 34: 1089-93.
31. Gris JC, Schved JF, Raffanel C, Dubois A. Impaired fibrinolytic capacity in patients with inflammatory bowel disease. Thromb Haemost 1990; 63: 472-5.
32. Utermann G, Menzel HJ, Kraft HG, Duba HC, Kemmler HG, Seitz C. Lp(a) glycoprotein phenoptypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J Clin Invest 1987; 80: 458-65.
33. Meade TW, Vickers MV, Thompson SG, Seghaatchian MJ. The effect of physiological levels of fibrinogen on platelet aggregation. Thromb Res 1985; 38: 527-34.
34. Lowe GDO, Drummond MM, Lorimer AR, Hutton I, Forbes CD, Prentice CRM, et al. Relation between extent of coronary artery disease and blood viscosity. BMJ 1980; i: 673-4.
35. Pittilo RM, Macklin IJ, Rowles PM, Machin SJ, Woolf N. Effects of cigarette smoking on the ultrastructure of the thoracic aorta and its ability to produce prostacyclin. Thromb Haemost 1982; 48: 173-6.
36. Bull HA, Pitillo RM, Woolf N, Machin SJ. The effect of nicotine on human endothelial cell release of prostaglandins and ultrastructure. Br J Exp Pathol 1988; 69: 413-21.
37. Osborne MJ, Stansby GP. Cigarette smoking and its relationship to inflammatory bowel disease: a review. J R Soc Med 1992; 85: 214-5.
38. Thompson NP, Wakefield AJ, Pounder RE. Inherited disorders of coagulation appear to protect against inflammatory bowel disease. Gastroenterology 1995; 108: 1011-5.